EpimAb_Logo_For Notified.png
EpimAb Biotherapeutics Announces Oral Presentation for EMB-06 (CND106) First-in-human (FIH) Phase I Study in Multiple Myeloma at the American Society of Hematology (ASH) 2024 Annual Meeting
December 05, 2024 20:00 ET | Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a global clinical stage biotechnology company specializing in the development of bispecific antibodies, is pleased to announce the...
22157.jpg
Complement Inhibitor Therapeutics Pipeline Developments Research Report 2024
December 05, 2024 10:36 ET | Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Complement Inhibitors - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest comprehensive analysis of the...
22157.jpg
Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
October 24, 2024 10:12 ET | Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides...
22157.jpg
PSMA Targeted Therapy Pipeline Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage
October 24, 2024 10:01 ET | Research and Markets
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "PSMA - Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on...
22157.jpg
Bispecific Antibody Drug Conjugates Market Opportunity Outlook 2024-2029: China Leads Over 35 Candidates, Key Companies Pioneering BsADC are Amgen, Innovent Biologics, AstraZeneca
October 14, 2024 05:52 ET | Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029" report has been added to...
EpimAb_Logo_For Notified.png
EpimAb Biotherapeutics Announces Upcoming Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 10, 2024 21:00 ET | Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI, Oct. 11, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased to...
EpimAb_Logo_For Notified.png
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
September 03, 2024 21:00 ET | Shanghai EpimAb Biotherapeutics Co., Ltd.
SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage biopharmaceutical company specializing in the...
22157.jpg
Global Biologics Contract Development and Manufacturing Organizations Market Report 2024-2029: End-to-end mRNA Services & Expanding Drug Capabilities to Support Anti-obesity Drugs Fuels Opportunities
July 31, 2024 09:41 ET | Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029" report has been added to ResearchAndMarkets.com's...
22157.jpg
Vulvar Cancer Pipeline Insight 2024, with Key Focus on TAK-242, Vudalimab, PEN-866, Artesunate, IRX-2, ISA101, VicOryx, PRV111, PRGN-2009, ABI-2280 and CUE-101
April 16, 2024 12:46 ET | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Vulvar Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
22157.jpg
Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029: 800+ Bispecific Candidates Currently in Active Clinical Development
March 18, 2024 05:16 ET | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...